NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108. A total of 72 filers reported holding NEXTCURE INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $194,000 | -28.1% | 150,000 | 0.0% | 0.00% | – |
Q2 2023 | $270,000 | +21.6% | 150,000 | 0.0% | 0.00% | – |
Q1 2023 | $222,000 | +4.7% | 150,000 | 0.0% | 0.00% | – |
Q4 2022 | $212,000 | -48.7% | 150,000 | 0.0% | 0.00% | -100.0% |
Q3 2022 | $413,000 | -41.4% | 150,000 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $705,000 | -3.3% | 150,000 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $729,000 | -19.1% | 150,000 | -0.2% | 0.00% | 0.0% |
Q4 2021 | $901,000 | -11.1% | 150,239 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $1,013,000 | -16.1% | 150,239 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $1,207,000 | -19.7% | 150,239 | 0.0% | 0.00% | -50.0% |
Q1 2021 | $1,504,000 | -8.2% | 150,239 | -0.1% | 0.00% | 0.0% |
Q4 2020 | $1,639,000 | +85.6% | 150,352 | +49.8% | 0.00% | +100.0% |
Q3 2020 | $883,000 | -59.0% | 100,352 | 0.0% | 0.00% | -75.0% |
Q2 2020 | $2,152,000 | -41.9% | 100,352 | +0.4% | 0.00% | -50.0% |
Q1 2020 | $3,707,000 | -34.2% | 100,000 | 0.0% | 0.01% | 0.0% |
Q4 2019 | $5,633,000 | – | 100,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sofinnova Investments, Inc. | 2,671,856 | $16,031,000 | 0.94% |
SILVERARC CAPITAL MANAGEMENT, LLC | 193,012 | $1,158,000 | 0.47% |
DAFNA Capital Management LLC | 187,696 | $1,126,000 | 0.28% |
Sio Capital Management, LLC | 130,000 | $780,000 | 0.24% |
Orbimed Advisors | 2,711,013 | $16,266,000 | 0.21% |
Long Focus Capital Management, LLC | 225,000 | $1,350,000 | 0.18% |
Lombard Odier Asset Management (Switzerland) SA | 407,291 | $2,444,000 | 0.16% |
Ikarian Capital, LLC | 134,055 | $804,000 | 0.12% |
Minerva Advisors LLC | 31,713 | $190,000 | 0.11% |
Anson Funds Management LP | 115,328 | $692,000 | 0.07% |